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Abstract
Background: Increasing use is being made of routinely collected electronic patient data in health services research. The aim of
the present study was to evaluate the potential usefulness of a comprehensive database used routinely in the public healthcare
system in Hong Kong, using antihypertensive drug prescriptions in primary care as an example.
Methods: Data on antihypertensive drug prescriptions were retrieved from the electronic Clinical Management System (e-
CMS) of all primary care clinics run by the Health Authority (HA) in the New Territory East (NTE) cluster of Hong Kong
between January 2004 and June 2007. Information was also retrieved on patients' demographic and socioeconomic
characteristics, visit type (new or follow-up), and relevant diseases (International Classification of Primary Care, ICPC codes).
Results: 1,096,282 visit episodes were accessed, representing 93,450 patients. Patients' demographic and socio-economic
details were recorded in all cases. Prescription details for anti-hypertensive drugs were missing in only 18 patients (0.02%).
However, ICPC-code was missing for 36,409 patients (39%). Significant independent predictors of whether disease codes were
applied included patient age ≥ 70 years (OR 2.18), female gender (OR 1.20), district of residence (range of ORs in more rural
districts; 0.32–0.41), type of clinic (OR in Family Medicine Specialist Clinics; 1.45) and type of visit (OR follow-up visit; 2.39).
In the 57,041 patients with an ICPC-code, uncomplicated hypertension (ICPC K86) was recorded in 45,859 patients (82.1%).
The characteristics of these patients were very similar to those of the non-coded group, suggesting that most non-coded patients
on antihypertensive drugs are likely to have uncomplicated hypertension.
Conclusion: The e-CMS database of the HA in Hong Kong varies in quality in terms of recorded information. Potential future
health services research using demographic and prescription information is highly feasible but for disease-specific research
dependant on ICPC codes some caution is warranted. In the case of uncomplicated hypertension, future research on pharmaco-
epidemiology (such as prescription patterns) and clinical issues (such as side-effects of medications on metabolic parameters)
seems feasible given the large size of the data set and the comparability of coded and non-coded patients.
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Background
The use of electronic patient records within healthcare sys-
tems has important implications for health services
research. When used within a comprehensive computer-
ized data management system such records can support
research into the aetiology of disease [1,2], the predictive
value of symptoms in diagnosis [3], the clinical effective-
ness and cost effectiveness of interventions [4], and in
evaluating whole-system approaches to the organization
and delivery of care [5]. The databases invariably contain
a large number of subjects, may provide almost complete
population coverage (depending on the healthcare and
data collection systems), often provide reliable informa-
tion on variables such as demographic characteristics, pre-
scribing patterns and diagnoses, and in theory allow for
quick and efficient data retrieval [6]. Notable examples
include the UK General Practice Research Database
(GPRD) [7], the Health Search Database in Italy [8], and
Ontario Drug Benefit (ODB) database [9]. Some data-
bases include almost all residents of a province [10,11],
thus enhancing the applicability and generalizability of
findings.
In many western countries these databases have been con-
structed in a systematic manner and influential study
results have been published [12-15]. There is a growing
trend for these evolving information systems to imple-
ment regional networks [16] and allow physician- or
patient- access to clinical information, as well as integra-
tion of a broader spectrum of patient data. Hong Kong ini-
tiated the operation of a comprehensive computerized
recording and management system in the public sector in
2000. All patient information, drug prescription details
and laboratory investigation results are routinely entered
into the electronic Clinical Management System (e-CMS)
for every consultation by health care professionals,
backed up by the Clinical Data Analysis Reporting System
(CDARS). Paper records will only be used during rare
occasions where computer systems are unexpectedly not
operational. These computerized databases thus far con-
sist of seven million patient records, one million annual
admissions and 13 million ambulatory visits, with medi-
cal research as one of the stated purposes of their imple-
mentation [17]. Nevertheless, the usefulness of these
clinical electronic databases in Hong Kong for high qual-
ity health services research has been little explored [17].
Hypertension is a good example of a common and impor-
tant condition which can be successfully researched using
comprehensive computerized patient records [8,18-21].
The prevalence of hypertension in Hong Kong has been
reported to exceed 27% and is one of the most common
conditions seen in public health sector [22], comparable
to the worldwide figure of 26% [23]. The public health
costs of hypertension are substantial [24,25] and repre-
sent an important area of health service research [26-30],
but there is a paucity of reports on health care utilization
patterns of this disease among Chinese patients. In the
present study we evaluated the completeness of the demo-
graphic and prescription details of patients recorded in
the e-CMS database of the HA in Hong Kong. Also we
examined the patterns and independent predictors of dis-
ease coding using antihypertensive drug prescriptions in
primary care as an example.
Methods
Data Source and Subjects
Clinical and demographic information were retrieved
from CDARS for all patients who attended HA primary
care clinics in the New Territory East (NTE) cluster of
Hong Kong, during the period from January 2004 to June
2007. We chose this time period because although e-CMS
was initiated in 2000, its implementation was gradual and
was severely interrupted by the SARS outbreak in 2003.
There was no requirement for doctors to enter the ICPC
codes into the CMS until post-SARS, which is also when
CDARS became operationalised. Thus January 2004 is the
earliest time point for the availability of both CDARS and
e-CMS data including ICPC codes.
The NTE cluster serves a population of around 1.3 million
in Hong Kong, representing 17.2% of the Hong Kong
population [31]. This cluster is further divided into 3 sep-
arate regions, namely Shatin, Tai-Po and the North Dis-
trict, from the most urbanized to the most rural regions
respectively. Their median monthly household incomes
in 2006 were US$2,510, US$2,338 and US$2,078 for
these three regions respectively, compared to the Hong
Kong-wide figure of US$2,240 [31]. These three regions
have similar median ages (38–39 years), comparable with
the median age of 39 years for Hong Kong.
Eligible subjects were those having received at least one
prescription of antihypertensive drugs in any of these pri-
mary care visits. Only visits which result in prescription of
antihypertensive drugs were included (hereafter named
"antihypertensive drug visits"). Since CDARS does not
have disease coding, we further obtained a list of patient
identity card (ID) numbers from CMS for various relevant
codes of the International Classification of Primary Care
(ICPC), including uncomplicated hypertension (K86)
and other conditions which could potentially affect the
prescription choice of antihypertensive drugs, which we
therefore refer to as "exclusion codes" (Table 1). These
codes were then merged with the information from
CDARS using the patients' ID as the unique identifier.
Patients were considered 'coded' if they had at least one
relevant ICPC code entered in the CMS during the study
period. The study was approved by the NTE cluster of HA,BMC Health Services Research 2008, 8:138 http://www.biomedcentral.com/1472-6963/8/138
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and the Survey and Behavioural Research Ethics Commit-
tee, Chinese University of Hong Kong
Variables and Statistical Analysis
All retrieved data were transformed and analyzed by the
Statistical Package for Social Sciences (SPSS) version 13.0.
The proportions of four distinct, mutually exclusive
patient groups were reported. These consist of (1). Those
coded with K86 and with exclusion coding ("combined
group"); (2). Those coded with K86 without any exclusion
coding ("K86-only group"); (3). Those not coded with
K86 but with at least one exclusion coding ("Exclusion
only group"); and (4). Those without K86 nor any exclu-
sion coding ("Non-coded group"). Among patients with
at least one code, the distribution of each coding was stud-
ied. The basic demographic and health service characteris-
tics of these different coding groups were compared using
χ2  tests of homogeneity and Analysis of Variance
(ANOVA) for categorical and continuous variables,
respectively. These include patient age, gender, payment
status (fee-waivers or service payers), district of residence,
service type (general out-patient, Family Medicine Spe-
cialist Clinic (FMSC), staff clinics) and appointment type
(new or subsequent visits) All these data were routinely
entered by clinic staffs when patients attended for consul-
tation, apart from service type. We further analyzed the
independent predictors of patients having received at least
one ICPC code, as those listed in Table 1, by physicians
using bivariate analysis, followed by multivariable analy-
sis by entering predictors with statistically significance
into a binary logistic regression equation. A forward step-
wise model was adopted and only those significant inde-
pendent predictors were reported. All p values <0.05 were
regarded as statistically significant.
Results
Overall patient breakdown
A total of 1,096,282 antihypertensive drug visits were
retrieved from January 2004 to June, 2007, representing
93,450 patients. Demographic and socio-economic
details were recorded for all patients. Prescription details
for anti-hypertensive drugs were missing in only 18
patients (0.02%), including drug dosage, frequency, or
prescription period, and a combination of these. Figure 1
shows the breakdown of disease coding relevant to anti-
hypertensive (anti-HT) drug prescriptions. Relevant ICPC-
codes were absent in 36,409 patients (39% of the total
sample); i.e., these patients had neither K86 nor any
exclusion code. The remaining 57,041 (61% of total)
patients had at least one relevant disease identified by an
ICPC code. Of these, 46,859 (50.1% of the total sample)
had uncomplicated hypertension (K86) coding, and
among these K86-coded patients, 16,155 patients
(17.2%) also had at least one additional (exclusion) code,
Table 1: Distribution of International Classification of Primary Care (ICPC) codes among patients with ≥ 1 code (N = 57,041)
ICPC codes Disease entity Reasons for exclusion number %
K87 Complicated hypertension The presence of unknown complications may favor or preclude 
prescription of a particular drug class
3310 5.8%
T90 Diabetes Mellitus Favors the choice of ACEIs 15560 27.3%
T901 Impaired glucose tolerance 353 0.6%
T92 Gout Contraindication of thiazide diuretics 635 1.1%
T93 Lipid disorders Favor the exclusion of thiazide diuretics and β-blockers 1186 2.1%
K90 Stroke/cerebrovascular accident Favor the choice of β-blockers 1920 3.4%
K91 Cerebrovascular disease 130 0.2%
K74 Ischemic Heart Disease with angina 348 0.6%
K76 Ischemic Heart Disease without angina 1099 1.9%
K75 Acute Myocardial Infarction 213 0.4%
K77 Heart Failure Favor the choice of ACEIs 794 1.4%
K84 Heart Disease, other Favor the choice of β-blockers or ACEIs 168 0.3%
K99 Cardiovascular disease, other 113 0.2%
R79 Chronic Bronchitis Contraindication of β-blockers 436 0.8%
R95 Chronic Obstructive Pulmonary Disease 2199 3.9%
R96 Asthma 1083 1.9%
U14 Kidney symptoms/complaints Either favor or a contraindication of ACEIs 312 0.5%
U88 Glomerulonephritis/nephrosis 36 0.1%
Y85 Benign Prostatic Hypertrophy Favor the prescription of α-blockers 2917 5.1%
U78 Benign Neoplasm Urinary Tract 30 0.1%
Y79 Benign/unspecified neoplasm, male genital 1 0.0%
(ACEIs: Angiotensin Converting Enzyme Inhibitors. There were a total of 46,859 patients (82.1%) Apart from K86 these conditions are influencing 
factors for antihypertensive drug prescription and were named "exclusion codes"BMC Health Services Research 2008, 8:138 http://www.biomedcentral.com/1472-6963/8/138
Page 4 of 9
(page number not for citation purposes)
resulting in 30,704 patients (32.9% of total) with uncom-
plicated hypertension (K86) without associated co-mor-
bidity (i.e., no exclusion codes).
Most of the patients were receiving calcium channel
blockers (49%) and β-blockers (46%), followed by angi-
otensin converting enzyme inhibitors (19%) and thiazide
diuretics (13%).
Distribution of codes and morbidities
Out of the 57,041 patients (61.0%) with at least one ICPC
disease code, the majority (82.1%) had uncomplicated
hypertension (K86) followed by diabetes mellitus (T90,
27.3%), complicated hypertension (K87, 5.8%) and
benign prostatic hypertrophy (Y85, 5.1%) (Table 1). The
coding proportions of other relevant diseases were low.
Among patients with at least one coded condition, 66.7%
had one code (or one condition) and 27.8% two or more
from the list of conditions shown in Table 1. Among
patients coded with K86, the figures are similar (65.5%
K86 only and 29.5% K86 coded with exclusion codes,
respectively).
Comparing patient characteristics among different coding 
groups
The whole study cohort had an average age of 64 years,
with the majority (61.2%) being 60 years old or over
(Table 2). Patients with uncomplicated hypertension
(K86-only group) had a similar age distribution to the
non-coded group. Overall there were more female than
male patients (Table 2). The K86-only and non-coded
groups had more female patients than the other two
groups. Almost half of all patients lived in the Shatin
region, which is the most urbanized area in the NTE clus-
ter (Table 2). More patients from the K86-only group lived
in the Shatin district than the other groups. The non-
coded group had the smallest proportion of patients resid-
ing in Shatin (33%).
Most patients attended the primary care general out-
patient clinics for antihypertensive drugs, but the exclu-
sion group had more patients who attended FMSC. The
distribution of service types was similar between the K86-
only group and the non-coded group. Overall more than
half of the patients were 'new' in terms of antihypertensive
drug visits during the study period. The non-coded group
had the greatest proportion of new visits (66%), almost
twice as high as in the combined group (34.0%).
Factors associated with disease coding
Multi-regression logistic regression was used to determine
the independent predictors of disease coding, i.e., the fac-
tors associated with whether a patient receiving antihyper-
tensive drugs had an ICPC disease code or not. Younger
patients (< 50 years) were less likely to be coded than
older patients (Table 3). Female patients were more likely
to be coded (aOR = 1.202, 95% C.I. 1.168, 1.238, p <
0.001). Patients living in Shatin district were more likely
to receive a code when compared to other less urbanized
regions (aOR range from 0.316 to 0.405). Patients visiting
family medicine specialist clinics were more likely to be
coded when compared to general out-patient clinics (aOR
= 1.448, 95% C.I. 1.362, 1.539, p < 0.001). Follow-up
cases were more likely to have a code (aOR = 2.394, 95%
C.I. 2.324, 2.467, p < 0.001). No significant association
was found between payment status and physician coding.
Discussion
Main findings
The present study shows that the public clinical databases
on antihypertensive drugs in Hong Kong are complete in
demographic and socio-economic data, and 99.98% com-
plete in prescription details. Among patients receiving
antihypertensive prescription in the primary care system,
the proportion having any relevant disease code was rela-
tively modest (61.0%) when compared with other prac-
tices in Western countries. About one third (32.9%) of
patients were identified as uncomplicated hypertensive
(K86-only) patients with no exclusion conditions. There
was similarity however between the K86-only group and
non-coded groups in age and gender distribution, pay-
ment status as well as service types, suggesting that most
non-coded patients probably had uncomplicated hyper-
tension. The important independent positive predictors of
having an ICPC code were advanced age, female gender,
residence in urbanized district, service type being family
medicine specialty, and follow-up case.
The breakdown of disease coding relevant to antihyperten- sive (anti-HT) drug prescriptions Figure 1
The breakdown of disease coding relevant to antihy-
pertensive (anti-HT) drug prescriptions.
1,096,282 visit episodes
(93,450 patients)
(patients on anti (patients on anti- -HT for unknown reasons) HT for unknown reasons)
Received 
> 1 anti-HT
In 2004-2007
No K86 
and no
exclusion
coding
36,409
Patients with  > 1 coding
(57,041 patients)
Patients coded K86,
AND without exclusion coding 
(30,704 patients)
(425,324 anti-HT drug visit episodes)
No K86
but with
Exclusion 
Codes
10,182
All Patients with K86 coding
(46,859 patients)
K86 coded + 
exclusion     
codes
16,155
Total
61.0%
50.1%
32.9%
of 
totalBMC Health Services Research 2008, 8:138 http://www.biomedcentral.com/1472-6963/8/138
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Interpretation of findings
The completeness of the demographic, socio-economic,
and prescribing details relate to the way in which this
information is organized and documented within the e-
CMS. Patient must register at first attendance and the
demographic and socio-economic data is entered directly
into the computer system by administrative staff in the
reception office. Prescriptions can only be issued via the
CMS, including private prescriptions. Thus we would
expect such data to be complete. ICPC codes on the other
hand are entered by the attending physicians during the
consultation. Most primary care clinics are extremely busy
(each doctor needs to handle 70–80 patients a day), and
short consultations are the norm rather than the exception
Thus it is perhaps unsurprising that ICPC codes were often
not entered into the e-CMS. Audit work has shown that
diagnoses are often entered into the hand written notes
rather than given an ICPC code (MCS Wong, unpublished
data).
The finding that older patients are more likely to be coded
can perhaps be explained by the presence of more mor-
bidities in the elderly group and perhaps more frequent
consulting (and hence likelihood of ICPC code being
entered on at least one occasion) which would also be the
case for the higher coding rates in the follow-up patients.
The coding difference in different districts of residence
may possibly be explained by the concentration of train-
ing centres and teaching clinics in Shatin. The similarly
higher coding rate in FMSC can also be explained by the
more stringent coding requirement of specialty clinics.
That higher likelihood of the female patients receiving a
code is also of interest and further exploration of the rea-
sons is needed.
Since completion of the current study, the NTEC, HA has
reinforced its ICPC coding policy and the coding rate for
all diseases as of July, 2007 has been reported to be 87.7%
[information provided by statistics team of the Hospital
Authority Head Office, November 2007]. Thus in future
Table 2: Patient characteristics according to K86 & exclusion coding
Coding K86 coded & 
without exclusion 
codes (n = 30,704)
K86 coded with 
exclusion codes (n 
= 16,155)
No K86 but with 
exclusion codes (n 
= 10,182)
No K86 & no 
exclusion codes 
(36,409)
All cases (n = 
93,450)
p value*
Patient "K86 only group" "combined group" "Exclusion group" "Non-coded group"
Age on appt. 
(no.%)
<50 4550(14.8) 1,073 (6.6) 791 (7.8) 7,484 (20.6) 13898(14.9) <0.001
50–59 8116(26.4) 2,814 (17.4) 1,804 (17.7) 9,704 (26.7) 22438(24.0)
60–69 6954(22.6) 4,191(25.9) 2,421 (23.8) 7,516 (20.6) 21082(22.6)
≥70 11084(36.1) 8,077 (50.0) 5,166 (50.7) 11,705 (32.1) 36032(38.6)
Mean Age on 
appt. (SD) (95% 
C.I.)
63.87(13.06) 68.22 (11.61) 68.45 (12.46) 61.77 (14.26) 64.30 (13.51) <0.001
(63.73, 64.02) (68.04, 68.40) (68.21, 68.69) (61.62, 61.91) (64.21, 64.39)
Gender (No./%)
Male 11,323 (36.9) 7,442 (46.1) 6,153 (60.4) 15,412 (42.3) 40330 (43.2) <0.001
Female 19,381 (63.1) 8,713 (53.9) 4,029 (39.6) 20,997 (57.7) 53120 (56.8)
Payment status
Fee-waivers 7,949 (25.9) 4,379 (27.1) 3,147 (30.9) 9,696 (26.6) 25,171 (26.9) <0.001
Non- waivers 22,755 (74.1) 11,776 (72.9) 7,035 (69.1) 26,713 (73.4) 68,279 (73.1)
District of 
residence
Shatin 18,510 (60.3) 8,817 (54.6) 5,524 (54.3) 12,120 (33.3) 44,971 (48.1) <0.001
Taipo 6,780 (22.1) 2,883 (17.8) 1,773 (17.4) 11,156 (30.6) 22,592 (24.2)
North 4,068 (13.2) 3,721 (23.0) 2,206 (21.7) 10,684 (29.3) 20,679 (22.1)
Others 1,346 (4.4) 734 (4.5) 679 (6.7) 2,449 (6.7) 5,208 (5.6)
Service type
General 28,946 (94.3) 13,881 (85.9) 7,523 (73.9) 34,524 (94.8) 84,874 (90.8) <0.001
FMSC/IC 1,625 (5.3) 2,260 (14.0) 2,618 (25.7) 1,673 (4.6) 8,176 (8.7)
Staff clinic 133 (0.4) 14 (0.1) 41 (0.4) 212 (0.6) 400 (0.4)
Appointment 
type (no./%)
New case 14,705 (47.9) 5,485 (34.0) 4,784 (47.0) 23,831 (65.5) 48,805 (52.2) <0.001
Old case 15,999 (52.1) 10,670 (66.0) 5,398 (53.0) 12,578 (34.5) 44,645 (47.8)
(*: Pearson Chi Square tests)BMC Health Services Research 2008, 8:138 http://www.biomedcentral.com/1472-6963/8/138
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work using this database substantially higher percentages
of disease coded data for patients with hypertension and
other chronic conditions seems likely.
Relationship to published literature
Many studies have used different diseases to validate local
databases. For the GPRD database in the UK, hospital
investigations and death certificates have been adopted to
support the validity of disease codes for deep vein throm-
bosis and pulmonary embolism [32]. Questionnaires
posted to general practitioners have been used to verify
the diagnosis and severity of chronic obstructive pulmo-
nary diseases for validation of the OXMIS codes of GPRD
[33]. Both studies found good agreement between data-
base disease codes and the tools used for validation, and
concluded that GPRD is of sufficiently high quality for
epidemiological research. Other methods for database
validation include the use of morbidity surveys and
national data to compare with database information
[34,35], which reported similar database usefulness.
Many studies on GPRD mainly focused on the complete-
ness and quality of computer recorded data [36,37].
GPRD has been used to address a variety of clinical issues,
including pharmaco-epidemiology and medication safety
[38], rheumatoid diseases [39,40], gout [41,42], diabetes
[43], and sexually transmitted infections [44], among oth-
ers. The GPRD in UK consists of information from prac-
tices which are up to standard, requiring the practice to
record a minimum of 95% of prescribing and relevant
patient-encounter events [45]. Also data from practices are
routinely under internal checks for validity [34], and each
practice will be sent a validation report after data collec-
tion.
We are unaware of any published work on validation of
the accuracy of disease codes in the HA e-CMS in Hong
Kong, but clearly this would be an important area for
future work if more rigorous health services research is
planned. However, a first step is the need for implementa-
tion of a quality control system and the necessary organi-
zational changes to ensure more complete data entry in
terms of ICPC disease codes.
Strengths and weaknesses of current study
The major strength of this study was the availability of a
large amount of electronic patient data on antihyperten-
sive medication over a three and a half year period from
which we could ascertain the potential and pitfalls of
using such data in health services research in the public
healthcare system in Hong Kong. We have done this in a
systematic way, and included robust statistical analysis to
aid interpretation.
Table 3: Associated factors of coding by physicians
Coding Coded* (n = 57,041) Non-coded(n = 36,409) Adjusted Odds Ratios** (95% C.I.) p value
Patient
Age on appt. (no.%)
<50 6,414(11.2) 7,484(20.6) 1.000 (reference)
50–59 12,735(22.3) 9,704(26.7) 1.364(1.302, 1.429) <0.001
60–69 13,566(23.8) 7,516(20.6) 1.774(1.692, 1.861) <0.001
≥70 24,327(42.6) 11,705(32.1) 2.180(2.088, 2.277) <0.001
Gender
Male 24,918(43.7) 15,412(42.3) 1.000 (reference)
Female 32,123(56.3) 20,997(57.7) 1.202(1.168,1.238) <0.001
Payment status
Fee-waivers 15,475(27.1) 9,696(26.6)
Payers 41,566(72.9) 26,713(73.4) Not significant
District of residence
Shatin 32,851(57.6) 12,120(33.3) 1.000 (reference)
Taipo 11,436(20.0) 11,156(30.6) 0.316(0.304, 0.327) <0.001
North 9,995(17.5) 10,684(29.3) 0.330(0.318, 0.343) <0.001
Others 2,759(4.8) 2,449(6.7) 0.405(0.381, 0.432) <0.001
Service type
General 50,350(88.3) 34,524(94.8) 1.000 (reference)
FMSC 6,503(11.4) 1,673(4.6) 1.448(1.362, 1.539) <0.001
Staff clinic 188(0.3) 212(0.6) 0.940(0.760, 1.162) 0.565
Appointment type (no./%)
New case 24,974(43.8) 23,831(65.5) 1.000 (reference)
Old case 32,067(56.2) 12,578(34.5) 2.394(2.324, 2.467) <0.001
(FMSC: Family Medicine Specialist Clinic. *Coded group refers to patients having at least one code, either K86 or exclusion coding. **represent 
odds ratios after controlling for all the predictor variables)BMC Health Services Research 2008, 8:138 http://www.biomedcentral.com/1472-6963/8/138
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However, this study also has some weaknesses. Firstly,
there are no external data to support the validity of the
database. We regarded the ICPC code as the 'gold stand-
ard' in categorizing our study cohort. The accuracy of
these codes however, has not been formally validated
against data from case notes or those from the secondary
care sector (which uses International Classification of Dis-
eases (ICD) codes). However, given the relatively straight-
forward diagnosis of uncomplicated hypertension we
believed the biases may be minimal. Secondly, these data
apply only to the NTE cluster, which represents only one
of seven organisational units within the HA in Hong
Kong. Thus we cannot know if the issues raised in the
study apply across the public healthcare system in Hong
Kong, although we have no reason to suspect that NTE is
different organizationally that other clusters. Thirdly, due
to gradual implementation of the e-CMS system and the
disruption of SARS in 2003 the present study could not
evaluate ICPC coding before 2004, and some of the 'un-
coded' patients in the present study could have been
coded by physicians pre-2004 into hand-written records
or free text space. However, since January 2004, all doctors
in the clinics are required to use the computer system as
the sole portal of information entry and patients with
ICPC codes in hand-written notes or free text before Janu-
ary 2004 should have had that information re-entered
into the e-CMS at consultations during the study period.
However, the ICPC code need only be entered once to be
counted as a 'coded patient' (not re-coded at every consul-
tation).
Implications for policy and practice
Hypertension is an important chronic disease globally
and locally in Hong Kong. The large numbers of electronic
patient records and completeness of some information
could potentially serve to help addressing this condition
in important areas of health services research, such as drug
prescription profiles and health service utilization pat-
terns. The scale of the database also has potential in clini-
cal epidemiological research with linkage between the
needs of the populations served, their geographical loca-
tion, and the availability of high quality primary care on
the basis of such needs. Data protection issues should
however be observed by researchers; the present database
is anonymized having only identity numbers without
patient contact details hence enhancing its data safety. In
practical terms, there are simple steps that can be initiated
at minimal cost, to enhance the quality of the e-CMS data.
For example, guidelines on ICPC coding for the clinical
staff may be helpful, and system changes which require
the entry of ICPC codes as compulsory rather than
optional. Our finding that more family medicine special-
ist clinics are likely to have coding supports the effective-
ness of routine data protocols in enhancing disease
coding rates, because these clinics are doctor training cent-
ers where data recording protocols are more stringently
managed and implemented. Further studies are needed to
validate the accuracy and completeness of CDARS and
C M S  i n  H o n g  K o n g  b y  m o r e  r i g o r o u s  t e s t i n g .  T h e s e
include comparison of cluster-representative surveys with
data generated for each disease entity to ensure they are
representative, and exploration of the disease status of
uncoded patients by case-note reviews to test whether the
uncoded group is likely to have uncomplicated hyperten-
sion only.
Since prescription details are virtually complete, this data-
base has the potential to study the patterns of antihyper-
tensive prescription, profiles of drug discontinuation and
switching, and the association of antihypertensive drug
class to clinical outcomes like mortality. Work is under-
way currently on all these areas of enquiry.
Conclusion
The e-CMS database of the HA in Hong Kong varies in
quality in terms of recorded information. Potential future
health services research using demographic and prescrip-
tion information is highly feasible but for disease-specific
research dependant on ICPC codes some caution is war-
ranted. In the case of uncomplicated hypertension, future
research on pharmaco-epidemiology (such as prescrip-
tion patterns) and clinical issues (such as side-effects of
medications on metabolic parameters) seems feasible
given the large size of the data set and the comparability
of coded and non-coded patients.
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